Genetic differences in the IGF-I gene among inbred strains of mice with different serum IGF-I levels

Journal of Endocrinology

Volumn 186, Issue 3, 2005, Pages 481-489

  Iida, K ^a   Rosen, C J ^b   Ackert Bicknell, C ^b   Thorner, M O ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; MESSENGER RNA; SOMATOMEDIN C; TRANSCRIPTION FACTOR E2F;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; LIVER LEVEL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SKELETAL MUSCLE; STRAIN DIFFERENCE;

ANIMALS; BASE SEQUENCE; GENE EXPRESSION PROFILING; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; POLYMORPHISM, GENETIC; RECEPTORS, SOMATOTROPIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY;

EID: 26044482961     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06200     Document Type: Article

References (45)

1. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL & D'Ercole AJ 1990 Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127 1033-1040.
2. Bugni JM, Poole TM & Drinkwater NR 2001 The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility. Carcinogenesis 22 1853-1862.
3. D'Ercole AJ, Stiles AD & Underwood LE 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. PNAS 81 935-939.
4. Domene HM, Bengolea SV, Martinez AS, Ropelato MG, Pennisi P, Scaglia P, Heinrich JJ & Jasper HG 2004 Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. New England Journal of Medicine 350 570-577.
5. Edens A & Talamantes F 1998 Alternative processing of growth hormone receptor transcripts. Endocrine Reviews 19 559-582.
6. Ge W, Davis ME, Hines HC, Irvin KM & Simmen RC 2003 Association of single nucleotide polymorphisms in the growth hormone and growth hormone receptor genes with blood serum insulin-like growth factor I concentration and growth traits in Angus cattle. Journal of Animal Science 81 641-648.
7. Giovannucci E 1999 Insulin-like growth factor-I and binding protein-3 and risk of cancer. Hormone Research 51 (Suppl 3) 34-41.
8. Gowri PM, Yu JH, Shaufl A, Sperling MA & Menon RK 2003 Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy. Molecular and Cellular Biology 23 815-825.
9. Hadjiyannakis S, Zheng H, Hendy GN & Goodyer CG 2001 GT repeat polymorphism in the 5′ flanking region of the human growth hormone receptor gene. Molecular and Cellular Probes 15 239-242.
10. Hale CS, Herring WO, Shibuya H, Lucy MC, Lubahn DB, Keisler DH & Johnson GS 2000 Decreased growth in angus steers with a short TG-microsatellite allele in the P1 promoter of the growth hormone receptor gene. Journal of Animal Science 78 2099-2104.
11. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R et al. 1996 Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. Journal of Clinical Investigation 98 2612-2615.
12. Iida K, Del Rincon JP, Kim DS, Itoh E, Nass R, Coschigano KT, Kopchick JJ & Thorner MO 2004a Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist. Endocrinology 145 1564-1570.
13. Iida K, Del Rincon JP, Kim DS, Itoh E, Coschigano KT, Kopchick JJ & Thorner MO 2004b Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice. American Journal of Physiology-Endocrinology and Metabolism 287 E566-E573.
14. Ishida BY, Blanche PJ, Nichols AV, Yashar M & Paigen B 1991 Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. Journal of Lipid Research 32 559-568.
15. Kaku K, McGill J, Province M & Permutt MA 1989 A single major gene controls most of the difference in susceptibility to streptozotocin-induced diabetes between C57BL/6J and C3H/HeJ mice. Diabetologia 32 716-723.
16. Kao PC, Matheny AP Jr & Lang CA 1994 Insulin-like growth factor-I comparisons in healthy twin children. Journal of Clinical Endocrinology and Metabolism 78 310-312.
17. Kayo T, Fujita H, Nozaki J, E X & Koizumi A 2000 Identification of two chromosomal loci determining glucose intolerance in a C57BL/6 mouse strain. Comparative Medicine 50 296-302.
18. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A et al. 2003 Growth hormone insensitivity associated with a STAT5b mutation. New England Journal of Medicine 349 1139-1147.
19. Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW & Kiel DP 1998 Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. Journal of Clinical Endocrinology and Metabolism 83 4257-4262.
20. Laron Z 2004 Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. Journal of Clinical Endocrinology and Metabolism 89 1031-1044.
21. Li S & Baserga R 1996 Epidermal growth factor and platelet-derived growth factor regulate the activity of the insulin-like growth factor I gene promoter. Experimental Gerontology 31 195-206.
22. Menon RK, Shaufl A, Yu JH, Stephan DA & Friday RP 2001 Identification and characterization of a novel transcript of the murine growth hormone receptor gene exhibiting development- and tissue-specific expression. Molecular and Cellular Endocrinology 172 135-146.
23. Moffat JG, Dao H & Talamantes F 2000 Alternative 5′-untranslated regions of mouse GH receptor/binding protein messenger RNA are derived from sequences adjacent to the major L2 promoter. Journal of Endocrinology 167 145-152.
24. Ooi GT, Hurst KR, Poy MN, Rechler MM & Boisclair YR 1998 Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells. Molecular Endocrinology 12 675-687.
25. Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC & Giovannucci E 1999 Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiology, Biomarkers and Prevention 8 1107-1110.
26. Procter AM, Phillips JA III & Cooper DN 1998 The molecular genetics of growth hormone deficiency. Human Genetics 103 255-272.
27. Rosen CJ, Dimai HP, Vereault D, Donahue LR, Beamer WG, Farley J, Linkhart S, Linkhart T, Mohan S & Baylink DJ 1997 Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 21 217-223.
28. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J & Bilezikian JP 1998 Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. Journal of Clinical Endocrinology and Metabolism 83 2286-2290.
29. Rosen CJ, Churchill GA, Donahue LR, Shultz KL, Burgess JK, Powell DR, Ackert C & Beamer WG 2000 Mapping quantitative trait loci for serum insulin-like growth factor-1 levels in mice. Bone 27 521-528.
30. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB & Wareham NJ 2002 Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359 1740-1745.
31. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X & Lusis AJ 2000 Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circulation Research 86 1078-1084.
32. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO et al. 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. PNAS 96 7088-7092.
33. Sjogren K, Wallenius K, Liu JL, Bohlooly YM, Pacini G, Svensson L, Tornell J, Isaksson OG, Ahren B, Jansson JO et al. 2001 Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50 1539-1545.
34. Sjogren K, Sheng M, Moverare S, Liu JL, Wallenius K, Tornell J, Isaksson O, Jansson JO, Mohan S & Ohlsson C 2002 Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. Journal of Bone and Mineral Research 17 1977-1987.
35. Stewart CE & Rotwein P 1996 Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiological Reviews 76 1005-1026.
36. Takahashi Y, Kaji H, Okimura Y, Goji K, Abe H & Chihara K 1996 Short stature caused by a mutant growth hormone. New England Journal of Medicine 334 432-436.
37. Takahashi Y, Shirono H, Arisaka O, Takahashi K, Yagi T, Koga J, Kaji H, Okimura Y, Abe H, Tanaka T et al. 1997 Biologically inactive growth hormone caused by an amino acid substitution. Journal of Clinical Investigation 100 1159-1165.
38. Wallenius K, Sjogren K, Peng XD, Park S, Wallenius V, Liu JL, Umaerus M, Wennbo H, Isaksson O, Frohman L et al. 2001 Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 142 4762-4770.
39. Woelfle J, Chia DJ & Rotwein P 2003 Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. Journal of Biological Chemistry 278 51261-51266.
40. Woods KA, Camacho-Hubner C, Savage MO & Clark AJ 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine 335 1363-1367.
41. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B & LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. PNAS 96 7324-7329.
42. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W & Le Roith D 2001 Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50 1110-1118.
43. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR et al. 2002 Circulating levels of IGF-I directly regulate bone growth and density. Journal of Clinical Investigation 110 771-781.
44. Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein ML, Kopchick JJ & LeRoith D 2004 Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. Journal of Clinical Investigation 113 96-105.
45. Yoshie M, Nishimori H, Lee GH & Ogawa K 1998 High colony forming capacity of primary cultured hepatocytes as a dominant trait in hepatocarcinogenesis-susceptible and resistant mouse strains. Carcinogenesis 19 1103-1107.